1-2 of 2
Keywords: Lymphokine-activated killer cells
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Influence of Immunotherapy (IL2 + LAK + Inhibition of Prostaglandin Synthesis) on Peripheral Blood Immune Parameters and in vitro Cytokine Production in Metastatic Renal Cell Carcinoma

Available to Purchase
Subject Area:
Further Areas
Sabine Kleinknecht, K. -Horst Bichler, Walter L. Strohmaier
Journal: Urologia Internationalis
Urol Int (1993) 50 (3): 121–128.
https://doi.org/10.1159/000282469
Published Online: 03 February 2010
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Metastatic renal cell carcinoma Interleukin 2 Lymphokine-activated killer cells Prostaglandin E 2 Peripheral blood mononuclear cell activity Immune status Cytokine...
View article titled, Influence of Immunotherapy (IL2 + LAK + Inhibition of Prostaglandin Synthesis) on Peripheral Blood Immune Parameters and in vitro Cytokine Production in Metastatic Renal Cell Carcinoma
Open the PDF for Influence of Immunotherapy (IL2 + LAK + Inhibition of Prostaglandin Synthesis) on Peripheral Blood Immune Parameters and in vitro Cytokine Production in Metastatic Renal Cell Carcinoma in another window
Journal Articles

Use of Biological Response Modifiers for Management of Renal Cell Carcinoma

Available to Purchase
Subject Area:
Further Areas
Mary Wilkinson, Frederick Aronson
Journal: Urologia Internationalis
Urol Int (1991) 46 (3): 304–308.
https://doi.org/10.1159/000282156
Published Online: 02 February 2010
... this otherwise lethal disease. Renal cell carcinoma Interleukin-2 Interferon-alpha Lymphokine-activated killer cells Tumor-infiltrating lymphocyte cells 2 2 2010 © 1991 S. Karger AG, Basel 1991 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...
View article titled, Use of Biological Response Modifiers for Management of Renal Cell Carcinoma
Open the PDF for Use of Biological Response Modifiers for Management of Renal Cell Carcinoma in another window